Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), and Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine ...

The arrangement will allow medicines to be built inside the United States from start to finish, Phlow's CEO said.

Phlow’s capital raise announcement came a day after Gov. Glenn Youngkin and British pharmaceutical firm AstraZeneca publicly ...

The new funding helps Phlow accelerate its mission to help make ingredients for medicines either considered in short supply ...

Richmond-based pharmaceutical manufacturing company Phlow announced Tuesday that it had secured $37 million in a capital raise.

No injuries were reported. The cause of the fire is still under investigation. Fire departments from surrounding localities assisted Petersburg with on-site and station-staffing support.

“Phlow has embarked on a bold mission to provide access to affordable, high-quality essential medicines for every American,” said Eric Edwards, M.D., Ph.D., co-founder, president and CEO of Phlow.

Phlow will lead a team of private sector entities that includes Civica Rx, a nonprofit created in 2018 by American hospitals to alleviate drug shortages; Ampac Fine Chemicals, a custom ...

From the Winter 2021/2022 issue of Inc. Magazine Eric Edwards, co-founder and CEO of Phlow. Photo: Courtesy company. Illustration: Inc. Magazine ...